Long-term reduction of relapse rate and confirmed disability progression after 6 years of ocrelizumab treatment in patients with relapsing multiple sclerosis
| Autor: | Giovannoni, G., Kappos, L., Hauser, S.L., Montalban, X., Koendgen, H., Prajapati, K., Manfrini, M., Mehta, L., Wolinsky, J. |
|---|---|
| Zdroj: | In Journal of the Neurological Sciences 15 October 2019 405 Supplement:308-309 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect